Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical Cannabis Aerosol Via Syqe Inhaler for Diabetic Peripheral Neuropathic Pain
NCT06490445Phase 2Completed
- Sponsor
- Syqe Medical
- Start
- Nov 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of dronabinol in diabetic polyneuropathy (DPN), sponsored by Syqe Medical. Started Nov 2024; status: completed.
02
Drugs
dronabinol
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT06490445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06490445.